REFERENCES
1. Rajendran P, Rengarajan T, Thangavel J, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9:1057-69.
2. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-7.
3. Bailey AS, Jiang S, Afentoulis M, et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood. 2004;103:13-9.
4. Fujisawa T, Tura-Ceide O, Hunter A, et al. Endothelial progenitor cells do not originate from the bone marrow. Circulation. 2019;140:1524-6.
5. Timmermans F, Van Hauwermeiren F, De Smedt M, et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol. 2007;27:1572-9.
6. Saito N, Shirado T, Funabashi-Eto H, et al. Purification and characterization of human adipose-resident microvascular endothelial progenitor cells. Sci Rep. 2022;12:1775.
7. Kawasaki T, Nishiwaki T, Sekine A, et al. Vascular repair by tissue-resident endothelial progenitor cells in endotoxin-induced lung injury. Am J Respir Cell Mol Biol. 2015;53:500-12.
8. Mao SZ, Ye X, Liu G, Song D, Liu SF. Resident endothelial cells and endothelial progenitor cells restore endothelial barrier function after inflammatory lung injury. Arterioscler Thromb Vasc Biol. 2015;35:1635-44.
9. Keighron C, Lyons CJ, Creane M, O'Brien T, Liew A. Recent advances in endothelial progenitor cells toward their use in clinical translation. Front Med. 2018;5:354.
10. Chopra H, Hung MK, Kwong DL, Zhang CF, Pow EHN. Insights into endothelial progenitor cells: origin, classification, potentials, and prospects. Stem Cells Int. 2018;2018:9847015.
11. Abdelgawad ME, Desterke C, Uzan G, Naserian S. Single-cell transcriptomic profiling and characterization of endothelial progenitor cells: new approach for finding novel markers. Stem Cell Res Ther. 2021;12:145.
12. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA. 2000;97:3422-7.
13. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600.
14. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24:288-93.
15. Michalska-Jakubus MM, Rusek M, Kowal M, Czop M, Kocki J, Krasowska D. Anti-endothelial cell antibodies are associated with apoptotic endothelial microparticles, endothelial sloughing and decrease in angiogenic progenitors in systemic sclerosis. Postepy Dermatol Alergol. 2020;37:725-35.
16. Kourek C, Briasoulis A, Zouganeli V, Karatzanos E, Nanas S, Dimopoulos S. Exercise training effects on circulating endothelial and progenitor cells in heart failure. J Cardiovasc Dev Dis. 2022;9:222.
17. Salybekov AA, Kobayashi S, Asahara T. Characterization of endothelial progenitor cell: past, present, and future. Int J Mol Sci. 2022;23:7697.
18. Chen Y, Wan G, Li Z, et al. Endothelial progenitor cells in pregnancy-related diseases. Clin Sci. 2023;137:1699-719.
19. Medina RJ, Barber CL, Sabatier F, et al. Endothelial progenitors: a consensus statement on nomenclature. Stem Cells Transl Med. 2017;6:1316-20.
20. Tasev D, Konijnenberg LS, Amado-Azevedo J, van Wijhe MH, Koolwijk P, van Hinsbergh VW. CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs). Angiogenesis. 2016;19:325-38.
21. Wang X, Wang R, Jiang L, Xu Q, Guo X. Endothelial repair by stem and progenitor cells. J Mol Cell Cardiol. 2022;163:133-46.
22. Duranova H, Valkova V, Olexikova L, et al. Rabbit endothelial progenitor cells derived from peripheral blood and bone marrow: an ultrastructural comparative study. Microsc Microanal. 2022;28:756-66.
23. Huang S, He P, Peng X, Li J, Xu D, Tang Y. Pristimerin inhibits prostate cancer bone metastasis by targeting PC-3 stem cell characteristics and VEGF-induced vasculogenesis of BM-EPCs. Cell Physiol Biochem. 2015;37:253-68.
24. Peng C, Yang LJ, Zhang C, et al. Low-dose nifedipine rescues impaired endothelial progenitor cell-mediated angiogenesis in diabetic mice. Acta Pharmacol Sin. 2023;44:44-57.
25. Yu JW, Deng YP, Han X, Ren GF, Cai J, Jiang GJ. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice. Cardiovasc Diabetol. 2016;15:88.
26. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858-64.
27. Leu S, Day YJ, Sun CK, Yip HK. tPA-MMP-9 axis plays a pivotal role in mobilization of endothelial progenitor cells from bone marrow to circulation and ischemic region for angiogenesis. Stem Cells Int. 2016;2016:5417565.
28. Zhang XY, Guo LP, Wang YZ, et al. TGF-β inhibition restores hematopoiesis and immune balance via bone marrow EPCs in aplastic anemia. Exp Mol Med. 2025;57:1324-38.
29. Ferrante A, Guggino G, Di Liberto D, et al. Endothelial progenitor cells: are they displaying a function in autoimmune disorders? Mech Ageing Dev. 2016;159:44-8.
30. Ramirez-Velandia F, Mensah E, Salih M, et al. Endothelial progenitor cells: a review of molecular mechanisms in the pathogenesis and endovascular treatment of intracranial aneurysms. Neuromolecular Med. 2024;26:25.
31. Dight J, Zhao J, Styke C, Khosrotehrani K, Patel J. Resident vascular endothelial progenitor definition and function: the age of reckoning. Angiogenesis. 2022;25:15-33.
32. Yang JX, Pan YY, Wang XX, Qiu YG, Mao W. Endothelial progenitor cells in age-related vascular remodeling. Cell Transplant. 2018;27:786-95.
33. Kou F, Zhu C, Wan H, et al. Endothelial progenitor cells as the target for cardiovascular disease prediction, personalized prevention, and treatments: progressing beyond the state-of-the-art. EPMA J. 2020;11:629-43.
34. Kwon YW, Heo SC, Jeong GO, et al. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis. Biochim Biophys Acta. 2013;1832:2136-44.
35. Lu W, Li X. Vascular stem/progenitor cells: functions and signaling pathways. Cell Mol Life Sci. 2018;75:859-69.
36. Qu K, Wang Z, Lin XL, Zhang K, He XL, Zhang H. MicroRNAs: Key regulators of endothelial progenitor cell functions. Clin Chim Acta. 2015;448:65-73.
37. Popovic D, Lavie CJ. Stress, cardiovascular diseases and exercise - a narrative review. Heart Mind. 2023;7:18-24.
38. Gill A, Aldosoky W, Ong MBH, Mir T, Dar T, Abohashem S. A narrative review on mental stress and cardiovascular disease: evidence, mechanisms, and potential interventions. Heart Mind. 2023;7:62-9.
39. Munir LZ, Du Toit EF. Impact of chronic psychological stress on cardiovascular disease risk: a narrative review. Heart Mind. 2024;8:268-78.
40. Araujo G, Valencia LM, Martin-Ozimek A, Soto Y, Proctor SD. Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins. Front Immunol. 2025;16:1485801.
41. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-7.
42. Wang W, Ye Y, Du Y, et al. EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation. Front Immunol. 2022;13:1019657.
43. Zhuo X, Bu H, Hu K, et al. Differences in the reaction of hyperlipidemia on different endothelial progenitor cells based on sex. Biomed Rep. 2021;15:64.
44. He Z, Chen Y, Hou C, He W, Chen P. Cigarette smoke extract changes expression of endothelial nitric oxide synthase (eNOS) and p16(INK4a) and is related to endothelial progenitor cell dysfunction. Med Sci Monit. 2017;23:3224-31.
45. Eleftheriadou I, Dimitrakopoulou N, Kafasi N, et al. Endothelial progenitor cells and peripheral neuropathy in subjects with type 2 diabetes mellitus. J Diabetes Complicat. 2020;34:107517.
46. Nelson J, Wu Y, Jiang X, et al. Hyperhomocysteinemia suppresses bone marrow CD34+/VEGF receptor 2+ cells and inhibits progenitor cell mobilization and homing to injured vasculature-a role of β1-integrin in progenitor cell migration and adhesion. FASEB J. 2015;29:3085-99.
47. Hagensen MK, Shim J, Thim T, Falk E, Bentzon JF. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation. 2010;121:898-905.
48. Hagensen MK, Raarup MK, Mortensen MB, et al. Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc Res. 2012;93:223-31.
49. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964-72.
50. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625-37.
51. Li L, Liu H, Xu C, et al. VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43. Stem Cell Res Ther. 2017;8:237.
52. Li B, Sharpe EE, Maupin AB, et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 2006;20:1495-7.
53. Yang H, He C, Bi Y, et al. Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells. Front Pharmacol. 2022;13:914347.
54. Liu G, Lu P, Li L, et al. Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. Mol Vis. 2011;17:2129-38.
55. Ozüyaman B, Ebner P, Niesler U, et al. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemostasis. 2005;94:770-2.
56. Behera J, Govindan S, Ramasamy MS. Nitric oxide promotes cell-matrix adhesion of endothelial progenitor cells under hypoxia condition via ITGA5 CpG promoter demethylation. Biochem Biophys Res Commun. 2023;644:162-70.
57. Bianchini E, Bianchini F, Lunardi M, et al. Outcomes, risk factors, and procedural management of acute myocardial infarction caused by stent thrombosis. Vessel Plus. 2024;8:20.
58. Khatana C, Saini NK, Chakrabarti S, et al. Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev. 2020;2020:5245308.
59. Kashirskikh DA, Guo S, Panyod S, et al. A novel insight into the nature of modified low-density lipoproteins and their role in atherosclerosis. Vessel Plus. 2023;7:3.
60. Meng Q, Li X, Yu X, Lei F, Jiang K, Li C. Transplantation of ex vivo expanded bone marrow-derived endothelial progenitor cells enhances chronic venous thrombus resolution and recanalization. Clin Appl Thromb Hemost. 2011;17:E196-201.
61. Massberg S, Konrad I, Schürzinger K, et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006;203:1221-33.
62. Abou-Saleh H, Yacoub D, Théorêt JF, et al. Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation. 2009;120:2230-9.
63. Modarai B, Burnand KG, Sawyer B, Smith A. Endothelial progenitor cells are recruited into resolving venous thrombi. Circulation. 2005;111:2645-53.
64. Wang W, Li C, Li W, et al. MiR-150 enhances the motility of EPCs in vitro and promotes EPCs homing and thrombus resolving in vivo. Thromb Res. 2014;133:590-8.
65. Feng Y, Lei B, Zhang H, et al. MicroRNA-136-5p from endothelial progenitor cells-released extracellular vesicles mediates TXNIP to promote the dissolution of deep venous thrombosis. Shock. 2022;57:714-21.
66. Hur J, Yang HM, Yoon CH, et al. Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation. 2007;116:1671-82.
67. Raemer PC, Haemmerling S, Giese T, et al. Endothelial progenitor cells possess monocyte-like antigen-presenting and T-cell-co-stimulatory capacity. Transplantation. 2009;87:340-9.
68. Naserian S, Abdelgawad ME, Lachaux J, et al. Development of bio-artificial micro-vessels with immunosuppressive capacities: a hope for future transplantations and organoids. Blood. 2019;134:3610.
69. Proust R, Ponsen AC, Rouffiac V, et al. Cord blood-endothelial colony forming cells are immunotolerated and participate at post-ischemic angiogenesis in an original dorsal chamber immunocompetent mouse model. Stem Cell Res Ther. 2020;11:172.
70. Chen Y, Jiang M, Chen X. Therapeutic potential of TNFR2 agonists: a mechanistic perspective. Front Immunol. 2023;14:1209188.
71. Arakelian L, Lion J, Churlaud G, et al. Endothelial CD34 expression and regulation of immune cell response in-vitro. Sci Rep. 2023;13:13512.
72. Weiss E, Vlahos A, Kim B, et al. Transcriptomic remodelling of fetal endothelial cells during establishment of inflammatory memory. Front Immunol. 2021;12:757393.
73. Tseng CN, Karlöf E, Chang YT, et al. Contribution of endothelial injury and inflammation in early phase to vein graft failure: the causal factors impact on the development of intimal hyperplasia in murine models. PLoS ONE. 2014;9:e98904.
74. Carracedo M, Artiach G, Arnardottir H, Bäck M. The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification. Semin Immunopathol. 2019;41:757-66.
75. Kijani S, Vázquez AM, Levin M, Borén J, Fogelstrand P. Intimal hyperplasia induced by vascular intervention causes lipoprotein retention and accelerated atherosclerosis. Physiol Rep. 2017;5:e13334.
76. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359-71.
77. Sun H, Morihara R, Feng T, et al. Human cord blood-endothelial progenitor cells alleviate intimal hyperplasia of arterial damage in a rat stroke model. Cell Transplant. 2023;32:9636897231193069.
78. Hutter R, Carrick FE, Valdiviezo C, et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation. 2004;110:2430-5.
79. Gilotti AC, Nimlamool W, Pugh R, et al. Heparin responses in vascular smooth muscle cells involve cGMP-dependent protein kinase (PKG). J Cell Physiol. 2014;229:2142-52.
80. Fang L, Chen MF, Xiao ZL, Yu GL, Chen XB, Xie XM. The effect of endothelial progenitor cells on angiotensin II-induced proliferation of cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol. 2011;58:617-25.
81. Zhang J, Chen J, Xu C, et al. Resveratrol inhibits phenotypic switching of neointimal vascular smooth muscle cells after balloon injury through blockade of Notch pathway. J Cardiovasc Pharmacol. 2014;63:233-9.
82. Mause SF, Ritzel E, Deck A, Vogt F, Liehn EA. Endothelial progenitor cells modulate the phenotype of smooth muscle cells and increase their neointimal accumulation following vascular injury. Thromb Haemostasis. 2022;122:456-69.
83. Mause SF, Ritzel E, Deck A, Vogt F, Liehn EA. Engagement of the CXCL12-CXCR4 axis in the interaction of endothelial progenitor cell and smooth muscle cell to promote phenotype control and guard vascular homeostasis. Int J Mol Sci. 2022;23:867.
84. Cao XN, Kong Y, Song Y, et al. Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant. Br J Haematol. 2018;182:870-86.
85. Medinger M, Heim D, Gerull S, et al. Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia. Leuk Res. 2016;47:22-5.
86. Yang CC, Sung PH, Cheng BC, et al. Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: a randomized, open-label, controlled phase II clinical trial. Stem Cells Transl Med. 2020;9:827-38.
87. Kundu N, Nandula SR, Asico LD, et al. Transplantation of apoptosis-resistant endothelial progenitor cells improves renal function in diabetic kidney disease. J Am Heart Assoc. 2021;10:e019365.
88. Tang SY, Lee YC, Tseng CW, Huang PH, Kuo KL, Tarng DC. Granulocyte colony-stimulating factor improves endothelial progenitor cell-mediated neovascularization in mice with chronic kidney disease. Pharmaceutics. 2023;15:2380.
89. Awal HB, Nandula SR, Domingues CC, et al. Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial. Cardiovasc Diabetol. 2020;19:72.
90. Shen S, Pan T, Liu P, Tian Y, Shi Y, Zhu W. The mechanisms and applications of endothelial progenitor cell therapy in the treatment of intracranial aneurysm. J Transl Med. 2025;23:377.
91. Zhang Y, Yang Q, Cheng H, Zhang Y, Xie Y, Zhang Q. Extracellular vesicles derived from endothelial progenitor cells modified by Houshiheisan promote angiogenesis and attenuate cerebral ischemic injury via miR-126/PIK3R2. Sci Rep. 2024;14:28166.
92. Yuan JJ, Yang J, Sun SL, Zhang R, Xu YM. Endothelial progenitor cells' classification and application in neurological diseases. Tissue Eng Regen Med. 2017;14:327-32.
93. Liu Y, Zhao X, Ding J, et al. Evidence of accumulated endothelial progenitor cells in the lungs of rats with pulmonary arterial hypertension by 89Zr-oxine PET imaging. Mol Ther Methods Clin Dev. 2020;17:1108-17.
94. Yamamoto K, Nishimura R, Kato F, et al. Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2020;299:263-70.
95. Kamel NM, Abd El Fattah MA, El-Abhar HS, Abdallah DM. Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways. Eur J Pharmacol. 2019;861:172620.
96. Tongers J, Roncalli JG, Losordo DW. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res. 2010;79:200-6.
97. Riesinger L, Saemisch M, Nickmann M, Methe H. CD34+ circulating cells display signs of immune activation in patients with acute coronary syndrome. Heart Vessels. 2018;33:1559-69.
98. Aries A, Zanetti C, Hénon P, Drénou B, Lahlil R. Deciphering the cardiovascular potential of human CD34+ stem cells. Int J Mol Sci. 2023;24:9551.
99. Losordo DW, Schatz RA, White CJ, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007;115:3165-72.
100. Losordo DW, Henry TD, Davidson C, et al. intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res. 2011;109:428-36.
101. Henry TD, Losordo DW, Traverse JH, et al. Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Eur Heart J. 2018;39:2208-16.
102. Zhang S, Ge J, Zhao L, et al. Host vascular niche contributes to myocardial repair induced by intracoronary transplantation of bone marrow CD34+ progenitor cells in infarcted swine heart. Stem Cells. 2007;25:1195-203.
103. Wang J, Zhang S, Rabinovich B, et al. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res. 2010;106:1904-11.
104. Mackie AR, Klyachko E, Thorne T, et al. Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ Res. 2012;111:312-21.
105. Roncalli J, Roubille F, Meyer N, et al. Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial. ESC Heart Fail. 2025;12:1455-63.
106. Co M, Tay E, Lee CH, et al. Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J. 2008;155:128-32.
107. Chong MS, Ng WK, Chan JK. Concise review: endothelial progenitor cells in regenerative medicine: applications and challenges. Stem Cells Transl Med. 2016;5:530-8.
108. Pelliccia F, Zimarino M, Niccoli G, et al. In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways. Eur Heart J Open. 2023;3:oead083.
109. Huang YH, Xu Q, Shen T, Li JK, Sheng JY, Shi HJ. Prevention of in-stent restenosis with endothelial progenitor cell (EPC) capture stent placement combined with regional EPC transplantation: An atherosclerotic rabbit model. Cardiol J. 2019;26:283-91.
110. Lu T, Sakuma M, Sohma R, et al. Mobilization of endothelial progenitor cells after implantation of CD34 antibody-covered sirolimus-eluting COMBO® stent: assessment with EPC colony-forming assay. Heart Vessels. 2025;40:435-45.
111. Goto H, Kitahara H, Matsumoto T, et al. Comparison of very early-phase vascular response to the CD34 antibody‑covered sirolimus‑eluting stent versus durable polymer-coated everolimus-eluting stent. Cardiovasc Interv Ther. 2025;40:527-35.
112. Garbuzova-Davis S, Willing AE, Ehrhart J, Wang L, Sanberg PR, Borlongan CV. Cell-free extracellular vesicles derived from human bone marrow endothelial progenitor cells as potential therapeutics for microvascular endothelium restoration in ALS. Neuromolecular Med. 2020;22:503-16.
113. Zhu J, Cheng X, Wang Q, Zhou Y, Wang F, Zou L. Transplantation of endothelial progenitor cells for improving placental perfusion in preeclamptic rats. Arch Gynecol Obstet. 2015;291:1113-9.
114. Pías-Peleteiro J, Pérez-Mato M, López-Arias E, et al. Increased endothelial progenitor cell levels are associated with good outcome in intracerebral hemorrhage. Sci Rep. 2016;6:28724.
115. Tartaglia JT, Eisenberg CA, DeMarco JC, Puccio G, Tartaglia CE, Hamby CV. Mobilization of endogenous CD34+/CD133+ endothelial progenitor cells by enhanced external counter pulsation for treatment of refractory angina. Int J Mol Sci. 2024;25:10030.
116. Sahoo S, Klychko E, Thorne T, et al. Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity. Circ Res. 2011;109:724-8.
118. Aries A, Vignon C, Zanetti C, et al. Development of a potency assay for CD34+ cell-based therapy. Sci Rep. 2023;13:19665.
119. Yuan F, Peng W, Yang Y, et al. Endothelial progenitor cell-derived exosomes promote anti-inflammatory macrophages via SOCS3/JAK2/STAT3 axis and improve the outcome of spinal cord injury. J Neuroinflammation. 2023;20:156.
120. Li P, Hong G, Zhan W, et al. Endothelial progenitor cell derived exosomes mediated miR-182-5p delivery accelerate diabetic wound healing via down-regulating PPARG. Int J Med Sci. 2023;20:468-81.
121. Tan W, Li Y, Ma L, et al. Exosomes of endothelial progenitor cells repair injured vascular endothelial cells through the Bcl2/Bax/Caspase-3 pathway. Sci Rep. 2024;14:4465.
122. Wu X, Liu Z, Hu L, Gu W, Zhu L. Exosomes derived from endothelial progenitor cells ameliorate acute lung injury by transferring miR-126. Exp Cell Res. 2018;370:13-23.
123. Forró T, Bajkó Z, Bălașa A, Bălașa R. Dysfunction of the neurovascular unit in ischemic stroke: highlights on microRNAs and exosomes as potential biomarkers and therapy. Int J Mol Sci. 2021;22:5621.
124. Schwarz N, Yadegari H. Potentials of endothelial colony-forming cells: applications in hemostasis and thrombosis disorders, from unveiling disease pathophysiology to cell therapy. Hamostaseologie. 2023;43:325-37.
125. Ju Y, Hu Y, Yang P, Xie X, Fang B. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration. Mater Today Bio. 2023;18:100522.
126. Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Correction: Gurunathan, S. et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 2019, 8, 307. Cells. 2021;10:462.
127. Hu H, Wang B, Jiang C, Li R, Zhao J. Endothelial progenitor cell-derived exosomes facilitate vascular endothelial cell repair through shuttling miR-21-5p to modulate Thrombospondin-1 expression. Clin Sci. 2019;133:1629-44.
128. Xu J, Bai S, Cao Y, et al. miRNA-221-3p in endothelial progenitor cell-derived exosomes accelerates skin wound healing in diabetic mice. Diabetes Metab Syndr Obes. 2020;13:1259-70.
129. Liu Y, Luo T, Li H, Zhao X, Zhou M, Cheng M. Protective effect of endothelial progenitor cell-derived exosomal microRNA-382-3p on sepsis-induced organ damage and immune suppression in mice. Am J Transl Res. 2022;14:6856-73.
130. Wang K, Dai X, He J, et al. Endothelial overexpression of metallothionein prevents diabetes-induced impairment in ischemia angiogenesis through preservation of HIF-1α/SDF-1/VEGF signaling in endothelial progenitor cells. Diabetes. 2020;69:1779-92.
131. Qi L, Ahmadi AR, Huang J, et al. Major improvement in wound healing through pharmacologic mobilization of stem cells in severely diabetic rats. Diabetes. 2020;69:699-712.
132. Yang J, Sun M, Cheng R, et al. Pitavastatin activates mitophagy to protect EPC proliferation through a calcium-dependent CAMK1-PINK1 pathway in atherosclerotic mice. Commun Biol. 2022;5:124.
133. Sun L, Zhang Y, Zhang J, Wang J, Xing S. Atorvastatin improves the proliferation and migration of endothelial progenitor cells via the miR-221/VEGFA axis. Biosci Rep. 2020;40:BSR20193053.
134. Nandula SR, Kundu N, Awal HB, et al. Role of canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes. Cardiovasc Diabetol. 2021;20:44.
